Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. [electronic resource]
Producer: 20060927Description: 668-75 p. digitalISSN:- 0923-7534
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- administration & dosage
- DNA Repair -- genetics
- Deoxycytidine -- administration & dosage
- Genotype
- Humans
- Lung Neoplasms -- drug therapy
- Polymorphism, Genetic
- Survival Analysis
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.